Patricia J. McLaughlin, an accomplished inventor based in Harrisburg, PA, has made significant contributions to the field of pharmaceutical sciences. With a remarkable portfolio of 15 patents, her work primarily focuses on innovative therapies for treating complex health conditions.

Latest Patents

Among her latest patents are notable inventions that target neoplasias and epithelial wounds. One significant patent is related to "Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptor." This invention encompasses pharmaceutical compositions designed to treat neoplasias in both animals and humans. It combines a carrier with therapeutically effective amounts of at least one chemotherapeutic agent alongside the biotherapeutic endogenous pentapeptide Met-enkephalin, known as the opioid growth factor. This patent also outlines methods for administering these compositions to individuals in need of such treatments.

Another noteworthy patent, "Methods and compositions for treatment of epithelial wounds," focuses on innovative methods for treating epithelial wounds using an opioid antagonist, particularly naltrexone. This invention aims to improve the healing processes for individuals suffering from such wounds, demonstrating McLaughlin's commitment to enhancing health outcomes.

Career Highlights

Patricia J. McLaughlin has built an impressive career, not only as an inventor but also through her affiliations with prominent organizations. She has been associated with The Penn State Research Foundation, where she focused on advancing research and development in her field. Her extensive background in pharmaceutical innovation has made her an influential figure in the industry.

Collaborations

Throughout her career, McLaughlin has collaborated with esteemed professionals, including Ian S. Zagon and Jill P. Smith. These collaborations reflect her dedication to teamwork and the importance of interdisciplinary approaches in advancing scientific research and innovation.

Conclusion

Patricia J. McLaughlin stands out as a pioneering inventor with a wealth of knowledge and innovation in the pharmaceutical domain. Her patents on combinatorial therapies and wound treatment underscore her significant impact on healthcare solutions. As she continues to evolve her extensive body of work, her contributions will undoubtedly inspire future advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.